Cargando…
Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645490/ http://dx.doi.org/10.1186/2051-1426-3-S2-P132 |
_version_ | 1782400824344838144 |
---|---|
author | Heery, Christopher R Donahue, Renee Lepone, Lauren Grenga, Italia Richards, Jacob Metenou, Simon Fernando, Romaine I Dirmeier, Ulrike Singh, Harpreet Madan, Ravi Gulley, James L Schlom, Jeffrey |
author_facet | Heery, Christopher R Donahue, Renee Lepone, Lauren Grenga, Italia Richards, Jacob Metenou, Simon Fernando, Romaine I Dirmeier, Ulrike Singh, Harpreet Madan, Ravi Gulley, James L Schlom, Jeffrey |
author_sort | Heery, Christopher R |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4645490 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46454902015-11-20 Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses Heery, Christopher R Donahue, Renee Lepone, Lauren Grenga, Italia Richards, Jacob Metenou, Simon Fernando, Romaine I Dirmeier, Ulrike Singh, Harpreet Madan, Ravi Gulley, James L Schlom, Jeffrey J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645490/ http://dx.doi.org/10.1186/2051-1426-3-S2-P132 Text en Copyright © 2015 Heery et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Heery, Christopher R Donahue, Renee Lepone, Lauren Grenga, Italia Richards, Jacob Metenou, Simon Fernando, Romaine I Dirmeier, Ulrike Singh, Harpreet Madan, Ravi Gulley, James L Schlom, Jeffrey Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses |
title | Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses |
title_full | Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses |
title_fullStr | Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses |
title_full_unstemmed | Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses |
title_short | Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses |
title_sort | phase i, dose-escalation, clinical trial of mva-brachyury-tricom vaccine demonstrating safety and brachyury-specific t cell responses |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645490/ http://dx.doi.org/10.1186/2051-1426-3-S2-P132 |
work_keys_str_mv | AT heerychristopherr phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses AT donahuerenee phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses AT leponelauren phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses AT grengaitalia phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses AT richardsjacob phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses AT metenousimon phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses AT fernandoromainei phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses AT dirmeierulrike phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses AT singhharpreet phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses AT madanravi phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses AT gulleyjamesl phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses AT schlomjeffrey phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses |